Navigation Links
MUHC scientists describe genetic resistance to rampant virus

MUHC researchers have defined genetic resistance to the widespread virus, cytomegalovirus (CMV)--a member of the viral group that causes some of the world's most prevalent diseases, such as herpes, chicken pox and mononucleosis. The groundbreaking research published in Nature Genetics last week, provides a roadmap for the development of human therapies for CMV, which could prolong the life of HIV patients and improve the success of transplant surgery by reducing the risk of rejection. There is currently no treatment or cure for CMV.

Resistance to diseases like CMV depends, at least partially, on the ability of our body's defense mechanism to recognize and destroy them. "Detecting these pathogens is not always easy," says Dr. Silvia Vidal, a Canada Research Chair in Host Response to Virus Infection based at the MUHC and lead author of the new research. "CMV has developed cunning disguises to avoid detection by our Natural Killer cells--one of several cell types that hunt-down and terminate unwelcome invaders within our body." Our Natural Killer cells and the pathogens they fight have been locked in an evolutionary arms race for millions of years in an attempt to overwhelm each other.

Dr. Vidal and her team have spent the past 10 years studying CMV-resistant mouse strains in an attempt to describe the nature of their genetic resistance. "This research marks our second discovery of genetic resistance to CMV," she says. Most significantly, this new research documents an entirely new mechanism of resistance to CMV, involving the interaction between two genes. One gene flags virus-infected cells for destruction, the other gene allows our Natural Killers cells to recognize and terminate them. "This is a new concept in natural disease resistance," notes Dr. Vidal. "Our research suggests there are many different mechanisms for fighting viruses; in the future we expect to discover additional resistant genotypes."

CMV infects most of the world's organism s, including upwards of 80% of the human population. Although healthy people suffer only mild symptoms, infection can trigger fatal reactions in those with a compromised immune system, such as organ transplant recipients, newborns and persons infected with human immunodeficiency virus (HIV). Dr. Vidal believes her groundbreaking discovery increases the likelihood that therapies will be developed to fight CMV.


'"/>

Source:McGill University


Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/11/2016)... , March 11, 2016 http://www.apimages.com ) - ... reference: Picture is available at AP Images ( http://www.apimages.com ) - ... will be used to produce the new refugee identity cards. DERMALOG ... innovations, at CeBIT in Hanover next week.   ... DERMALOG will be used to produce the new refugee identity cards. ...
(Date:3/10/2016)... 10, 2016   Unisys Corporation (NYSE: UIS ... (CBP) is testing its biometric identity solution at the ... to help identify certain non-U.S. citizens leaving the country. ... designed to help determine the efficiency and accuracy of using ... and will run until May 2016. --> ...
(Date:3/9/2016)... GARDENS, Fla. , March 9, 2016 /PRNewswire/ ... management authentication and enrollment solutions, today announced the ... DigitalPersona ® Altus multi-factor authentication platform. ... and InfoSec managers to step-up security where it,s ... Washington, DC . ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... PARIS , April 27, 2016 ... system disorders, today announces the appointment of Catherine Moukheibir as ... succeed MedDay,s previous Chairman, Jean Jacques Garaud , who ... The change is effective immediately. Catherine started her ... Boston and London .  She ...
(Date:4/26/2016)... (PRWEB) , ... April 26, 2016 , ... ... today announced that Ardy Arianpour has joined the company as Chief Business Officer. ... experience bringing innovative genomic technologies to market, was most recently Chief Commercial Officer ...
(Date:4/26/2016)... ... April 26, 2016 , ... Mr. Palmer created the RPO business for Ceridian ... dollar, multi-year managed services contract in the U.S. intelligence community with The SI (a ... said John Younger, founder of Accolo. “We are growing and his experience guiding ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based non-profit, The ... from 1Plus12 Corporation. The grant will be used to further the scientific research ... organization's website http://www.ivsci.org , In accounting the grant to the IVS, ...
Breaking Biology Technology: